CytoMed Therapeutics GDTC
NASDAQ GDTC
$0.90 +0.06 (+6.75%)
At close: Oct 1, 2026 · 4:00 PM EDT

CytoMed Therapeutics (GDTC) Current Leases (2021 - 2025)

Updated

CytoMed Therapeutics (GDTC) recorded Current Leases of $53,461 in Q4 2025, up 132.2% from $23,028 a year earlier.

Analysis

CytoMed Therapeutics (GDTC) Current Leases (2021 - 2025) Analysis & Trends

Starting with Q4 2021, CytoMed Therapeutics' Current Leases history includes 5 quarters.

  • Annual Current Leases has a four-year compound annual growth rate of 36.7% (FY2021 to FY2025).
  • Across earlier years, Current Leases came in at $23,028 in FY2024, $6,709 in FY2022 (-56.2%) and $15,318 in FY2021.
  • Quarterly Current Leases has ranged from $6,709 in Q4 2022 to $59,267 in Q2 2025 over the past five years.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Current Leases (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn -
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn -
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn -
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn 274.00 Mn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn -2.32 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn -
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn -
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn -
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn -
10 CytoMed Therapeutics 9.94 Mn -1.15 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 53,461.00
Jun 30, 2025 59,267.00
Dec 31, 2024 23,028.00
Dec 31, 2022 6,709.00
Dec 31, 2021 15,318.00
API Access

CytoMed Therapeutics Current Leases API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=current-leases&ticker=GDTC&period=max&api_key=YOUR_API_KEY